🕵️ RAPT Therapeutics, Inc. ($RAPT)
SEC insider & ownership activity, last 12 months · CIK 1673772 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Mar 3, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Medicxi IV Gp Limited | 16.9% | 13G | Jan 6, 2025 | filing ↗ | |
| Medicxi Ventures Management (JERSEY) Limited | 16.9% | 13G | Jan 6, 2025 | filing ↗ | |
| Medicxi IV LP | 16.6% | 13G | Jan 6, 2025 | filing ↗ | |
| TCG Crossover GP II, LLC | 10.0% | 13G | Jan 3, 2025 | filing ↗ | |
| TCG Crossover Fund II, L.P. | 10.0% | 13G | Jan 3, 2025 | filing ↗ | |
| Chen Yu | 10.0% | 13G | Jan 3, 2025 | filing ↗ | |
| Redmile Group, LLC | 9.9% | 13G | Aug 14, 2025 | filing ↗ | |
| Jeremy C. Green | 9.9% | 13G | Aug 14, 2025 | filing ↗ | |
| DEEP Track Capital, LP | 9.9% | 13G | Dec 23, 2024 | filing ↗ | |
| DEEP Track Biotechnology Master Fund, Ltd. | 9.9% | 13G | Dec 23, 2024 | filing ↗ | |
| David Kroin | 9.9% | 13G | Dec 23, 2024 | filing ↗ | |
| Foresite Capital Fund VI, L.P. | 9.3% | 13G | Dec 30, 2024 | filing ↗ | |
| Foresite Capital Management VI, LLC | 9.3% | 13G | Dec 30, 2024 | filing ↗ | |
| James Tananbaum | 9.3% | 13G | Dec 30, 2024 | filing ↗ | |
| Roderick WONG, M.D. | 8.9% | 13G | May 15, 2025 | filing ↗ | |
| Forgrowth III Pa B.v. | 7.4% | 13G | Oct 29, 2025 | filing ↗ | |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 7.4% | 13G | Oct 29, 2025 | filing ↗ | |
| Forbion Growth III Management B.V. | 7.4% | 13G | Oct 29, 2025 | filing ↗ | |
| Redmile Biopharma Investments III, L.P. | 6.5% | 13G | Aug 14, 2025 | filing ↗ | |
| Glazer Capital, LLC | 5.4% | 13G | Feb 9, 2026 | filing ↗ | |
| Paul J. Glazer | 5.4% | 13G | Feb 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Acquisition or disposition (2.01) | Mar 3, 2026 | filing ↗ |
| Delisting notice (3.01) | Mar 3, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 3, 2026 | filing ↗ |
| Change of control (5.01) | Mar 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 14, 2026 | filing ↗ |
| Officer/director changes (5.02) | Nov 24, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Other events (8.01) | Oct 21, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 21, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 20, 2025 | filing ↗ |
| Other events (8.01) | Oct 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 20, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |